Sitagliptin (SITA), a dipeptidyl peptidase-4 (DPP-4) inhibitor, is a widely used drug for managing Type 2 diabetes by increasing the levels of incretin hormones, which promote insulin secretion [11]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.